AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$4.14
-0.60%
Mkt Cap $1.23B
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$20.17
Range $5.00 – $34.00
Implied Upside
+387.8%
Consensus $20.17 vs current $4.14
NASDAQ·Healthcare·Biotechnology
$4.14
-0.60%
Mkt Cap $1.23B
No recent rating data.
Price Target (7 analysts)
$20.17
Range $5.00 – $34.00
+387.8%
Consensus $20.17 vs current $4.14